Vanda Pharmaceuticals Inc. (VNDA): EPS (Basic)
-$3.74
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$3.74 | n/m | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | -$0.33 | n/m | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $0.04 | -63.6% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $0.11 | -81.7% | 2025-02-14, From 2022-01-01 |
| 2021-12-31 | $0.60 | +39.5% | 2024-02-08, From 2021-01-01 |
| 2020-12-31 | $0.43 | -80.2% | 2023-02-09, From 2020-01-01 |
| 2019-12-31 | $2.17 | +334.0% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $0.50 | n/m | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | -$0.35 | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | -$0.41 | n/m | 2019-02-19, From 2016-01-01 |
| 2015-12-31 | -$0.94 | n/m | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $0.58 | n/m | 2017-02-17, From 2014-01-01 |
| 2013-12-31 | -$0.69 | n/m | 2016-02-12, From 2013-01-01 |
| 2012-12-31 | -$1.01 | n/c | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | -$0.35 | n/m | 2014-02-25, From 2011-01-01 |
| 2010-12-31 | $0.26 | n/m | 2013-02-26, From 2010-01-01 |
| 2009-12-31 | -$1.33 | n/a | 2012-03-09, From 2009-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. (VNDA) | 2025-12-31 | -$3.74 | n/m |
| Amarin Corp PLC (AMRN) | 2025-12-31 | -$0.09 | n/m |
| IDEAYA Biosciences, Inc. (IDYA) | 2025-12-31 | -$1.28 | n/m |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $0.62 | 0.0% |
| Anaptysbio, Inc (ANAB) | 2025-12-31 | -$0.46 | n/m |
| Akebia Therapeutics, Inc. (AKBA) | 2025-12-31 | -$0.02 | n/m |
| Keros Therapeutics, Inc. (KROS) | 2025-12-31 | $2.34 | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$3.11 | n/m |
| Arcus Biosciences, Inc. (RCUS) | 2025-12-31 | -$3.29 | n/m |
Compare VNDA, AMRN, IDYA, PBYI side by side · Screen every company in Pharmaceutical Preparations ↗